Financial Data and Key Metrics Changes - Total revenue increased from $29.3 million in Q4 2024 to $30.9 million in Q4 2025, representing a 5.6% annual growth [11] - FFO in Q4 2025 was $13.3 million, a 4.6% increase year-over-year compared to $12.7 million in Q4 2024 [13] - AFFO totaled $14.9 million in Q4 2025, a 2.1% increase year-over-year from $14.6 million in Q4 2024 [14] - The company declared a dividend of $0.4775 per common share for Q4 2025, raising the annualized dividend to $1.91 per share [10] Business Line Data and Key Metrics Changes - Occupancy increased from 90.1% to 90.6% during the quarter [6] - The weighted average lease term increased from 6.7 years to 7 years [6] - The company sold an inpatient rehab facility at a 7.9% cap rate, resulting in a gain of approximately $11.5 million [7] Market Data and Key Metrics Changes - The company acquired three properties totaling 113,000 sq ft for $64.5 million, which were 100% leased [8] - The expected return on new investments ranges from 9.1% to 9.75% [9] - The indicative cap rate for the sale of the inpatient rehab facility was 7.9%, with expectations for similar pricing on other dispositions [26] Company Strategy and Development Direction - The company is focused on capital recycling and selective acquisitions, maintaining modest leverage levels [9][23] - There are ongoing redevelopment projects expected to come online in mid-2026 and late 2026, which are anticipated to provide growth [27] - The company aims to execute transactions without adding meaningful leverage to the balance sheet [24] Management's Comments on Operating Environment and Future Outlook - Management noted that the transaction with the behavioral hospital operator is progressing, with expectations for a simultaneous closing of all six hospitals [20] - Leasing activity is strong, and management expects occupancy to remain stable in the low nineties for the next couple of quarters, with potential growth in the second half of the year [32] - The company sees a high level of demand for its assets and is optimistic about future acquisition opportunities [26][34] Other Important Information - The company has signed definitive purchase and sale agreements for five properties expected to be acquired after completion and occupancy [9] - The company did not issue any shares under its ATM last quarter, indicating a focus on using capital from asset sales for acquisitions [9] Q&A Session Summary Question: Update on the JRF Behavioral Hospital operator transaction - Management indicated that the transaction is expected to occur all at once, with no plans for a staged closing [20] Question: Balancing transactions and potential leverage increases - Management emphasized the goal of sequencing dispositions and acquisitions to maintain leverage levels [23] Question: Changes in cap rates for acquisitions or dispositions - Management noted a high demand for assets and expected similar pricing on other dispositions [26] Question: Future occupancy expectations - Management anticipates occupancy to remain stable in the low nineties for the next couple of quarters, with potential increases in the second half of the year [32] Question: Investment pipeline and opportunities - Management confirmed that opportunities still exist, and they are in touch with brokers to identify potential acquisitions [34] Question: Status of the dialysis term sheet pipeline - Management stated that the relationship is on the back burner, with no immediate focus on executing transactions [36]

Financial Data and Key Metrics Changes - Total revenue increased from $29.3 million in Q4 2024 to $30.9 million in Q4 2025, representing a 5.6% annual growth [11] - FFO in Q4 2025 was $13.3 million, a 4.6% increase year-over-year compared to $12.7 million in Q4 2024 [13] - AFFO totaled $14.9 million in Q4 2025, a 2.1% increase year-over-year from $14.6 million in Q4 2024 [14] - Interest expense decreased slightly to $7 million in Q4 2025, primarily due to recent FOMC interest rate cuts [12] Business Line Data and Key Metrics Changes - Occupancy increased from 90.1% to 90.6% during the quarter, with a weighted average lease term rising from 6.7 to 7 years [6] - The company sold an inpatient rehab facility at a 7.9% cap rate, resulting in a gain of approximately $11.5 million [7] - Acquired three properties totaling 113,000 sq ft for $64.5 million, all 100% leased with anticipated annual returns of 9.3%-9.5% [8] Market Data and Key Metrics Changes - The company received a 7.9% cap rate on the sale of the inpatient rehab facility and expects similar pricing on other dispositions [27] - Opportunities on the buy side are seen in the 9%-10% cap rate range [27] Company Strategy and Development Direction - The company is focused on capital recycling and selective acquisitions, with plans to maintain modest leverage levels [9] - Future acquisitions are expected to be funded through selected asset sales and revolver capacity [9] - The company anticipates significant growth from redevelopment projects expected to come online in mid-2026 and late 2026 [28] Management's Comments on Operating Environment and Future Outlook - Management noted that the transaction with the behavioral hospital operator is expected to occur all at once, with no plans for a staged closing [20] - The company expects leased occupancy to remain stable in the low nineties for the next couple of quarters, with potential growth in the second half of the year [33] - Management remains optimistic about the investment pipeline, indicating that opportunities still exist despite recent challenges [36] Other Important Information - The company declared a dividend of $0.4775 per common share for Q4 2025, marking a continuous increase since the IPO [10] - The company has signed definitive purchase and sale agreements for five properties expected to close between 2026 and 2027 [9] Q&A Session Summary Question: Update on the JRF Behavioral Hospital operator transaction - Management indicated that the transaction is expected to happen all at once, with significant progress anticipated in the first quarter [20] Question: Balancing transactions and potential increase in debt levels - Management aims to sequence dispositions and acquisitions effectively, maintaining current leverage levels without adding more [22][24] Question: Changes in cap rates for acquisitions or dispositions - Management noted a high demand for assets and expects similar cap rates for future dispositions, with opportunities in the 9%-10% range for acquisitions [27] Question: Expectations for occupancy rates - Management expects occupancy to remain stable in the low nineties for the next couple of quarters, with potential increases in the second half of the year [33] Question: Investment pipeline and opportunities - Management confirmed that opportunities still exist in the market, with a focus on both client business and brokered deals [36]

LISTED NYSE CHCT Investor Presentation February 2026 [TBU] Investor Presentation November 2020 At a Glance Community Healthcare Trust, Inc. NYSE: CHCT Market Data (as of December 31, 2025) Closing Price: $16.42 52 Week Range: $20.87 / $13.23 Market Cap: $467.5 million Enterprise Value: $996.4 million less % of Annualized Rent more 42nd Consecutive Quarter of Dividend Growth 198 Properties 323 Tenants 36 States Investor Presentation – February 2026 2 R: 0 G: 51 B: 160 R: 100 G: 100 B: 100 R: 0 G: 93 B: 170 R ...

Core Insights - The company is maintaining strategic selectivity in acquisitions to avoid issuing equity at current price levels, focusing on supporting existing client relationships [1] - Management is managing a tenant transition for six geriatric behavioral hospitals, with the buyer currently in due diligence, involving complex government-related liability verifications [1] - Interest expense has decreased slightly due to FOMC interest rate cuts impacting floating rates on the revolving credit facility [1] Group 1 - The company executed a 1031 like-kind exchange, selling an inpatient rehab facility at a 7.9% cap rate and reinvesting in a new facility at a 9.3% return to reduce tenant concentration [2] - Occupancy improved from 90.1% to 90.6% during the quarter, driven by active leasing and renewals, extending the weighted average lease term to seven years [2] Group 2 - Management attributed the slight quarter-over-quarter revenue decrease to the timing of capital recycling and asset disposition activity rather than underlying portfolio weakness [3] - The company expects embedded growth in 2026 from two major redevelopment projects, with the largest slated for rent commencement in the third quarter of 2026 [3] - Future acquisition volume is expected to focus on programmatic client business until the share price allows for accretive capital raises to resume brokered deal activity [3] - The company has $122.5 million in definitive purchase agreements for five properties to be acquired upon completion through 2027 at returns between 9.1% and 9.75% [3]

Core Insights - Neo Ivy Capital Management has initiated a new position in American Healthcare REIT by purchasing 136,925 shares valued at approximately $6.44 million [2][8] - American Healthcare REIT has demonstrated strong financial performance, with a 16.4% same-store NOI growth in the third quarter, driven by significant increases in senior housing and integrated senior health campuses [7][10] - The company's stock price has increased by 93.3% over the past year, outperforming the S&P 500 with a one-year alpha of 80.37 percentage points [8] Company Overview - American Healthcare REIT operates a diversified portfolio of healthcare properties, including medical office buildings, senior housing communities, and skilled nursing facilities across the U.S. and U.K. [6][9] - The company has a market capitalization of $9.65 billion and reported a revenue of $2.20 billion for the trailing twelve months [4] - The dividend yield stands at 1.92%, indicating a return to shareholders [4] Financial Performance - GAAP net income attributable to controlling interest was reported at $55.9 million, equating to $0.33 per diluted share, while normalized FFO was $0.44 per share [10] - Management has raised full-year NFFO guidance to a range of $1.69 to $1.72, with expectations for same-store NOI growth reaching as high as 15% [10] Investment Implications - The new position by Neo Ivy Capital Management represents 1.02% of its reportable assets, indicating a strategic allocation to tap into healthcare real estate momentum [8][11] - The investment thesis for long-term investors is based on sustained occupancy rates above 90% in senior housing and disciplined capital allocation [11]

Core Insights - CareTrust REIT experienced a transformational year in 2025, achieving record investment activity and expanding its team significantly, which supports its growth strategy in the UK and seniors housing sectors [5][7]. Investment Activity - CareTrust reported total investments of $1.8 billion in 2025, surpassing its previous record set in 2024, which contributed to a 17.3% year-over-year growth in normalized FFO per share [2][7]. - The fourth quarter alone saw approximately $562 million in investments, including CareTrust's first SHOP deal involving three Texas communities with 270 units [7][8]. - The company's investment pipeline is approximately $500 million, with a focus on UK care homes and U.S. skilled nursing facilities [12]. Financial Performance - In the fourth quarter, normalized FFO increased by 42.7% quarter-over-quarter to $104.1 million, with a normalized FFO per share increase of 17.5% to $0.47 [14]. - For the full year, normalized FFO per share rose by 17.3% to $1.76, while normalized FAD per share increased by 14.3% to $1.76 [14]. Guidance and Future Outlook - CareTrust provided guidance for 2026, projecting normalized FFO per share between $1.90 and $1.95, indicating a midpoint growth of approximately 9.4% year-over-year [6][19]. - The company is entering 2026 with strong liquidity, including around $100 million in cash and a $1.2 billion revolving credit facility, alongside low leverage metrics [17]. Strategic Initiatives - The company doubled its professional team in 2025 and executed strategic initiatives, including the acquisition of Care REIT to enter the UK care home market [3][5]. - Management emphasized ongoing diversification across geography, asset types, and operator relationships, which is expected to enhance growth opportunities [2][4]. Market Position and Competition - CareTrust is experiencing competitive conditions in the SHOP sector, with cap rates compressing as investors seek exposure to improving operating trends [13]. - The company maintains a focus on achieving unlevered IRR in the low double digits for its SHOP investments, while also exploring opportunities in the UK market [21][23].

Strategic. Disciplined. Opportunistic. Investor Presentation | February 12, 2026 Disclaimers Forward-Looking Statements This presentation contains "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Any statements that do not relate to historical or current facts or matters are forward-looking statements. These statements may be identified, without limitation, by the use of "expects," "believes," "intends," "should" or comparable terms or the negative thereof. Ex ...

Core Viewpoint - Northwest Healthcare Properties Real Estate Investment Trust (REIT) has declared a distribution of $0.03 per unit for February 2026, which annualizes to $0.36 per unit, payable on March 13, 2026, to unitholders of record as of February 27, 2026 [1]. Company Overview - Northwest Healthcare Properties REIT is a prominent owner and operator of healthcare real estate infrastructure across North America, Brazil, Europe, and Australasia [2]. - As of November 11, 2025, the REIT's portfolio includes 167 income-producing properties with a total gross leasable area of 15.7 million square feet, located in major markets [2]. - The portfolio consists of medical outpatient buildings, clinics, and hospitals, characterized by long-term indexed leases and stable occupancy rates [2]. - The company operates in eight countries, leveraging a global workforce to partner with leading healthcare operators [2].

Core Insights - Ventas reported an "outstanding year" in 2025, driven by strong performance in senior housing under its "1, 2, 3 strategy" focusing on organic growth, value-creating investments, and cash flow [3] Financial Performance - Fourth-quarter same-store SHOP revenue grew over 8%, with occupancy growth of 300 basis points year-over-year and 100 basis points sequentially [1] - Normalized FFO per share increased by 9% in 2025, while same-store SHOP cash NOI grew by 15%, marking the fourth consecutive year of double-digit growth [2][5] - Ventas' enterprise value exceeded $50 billion, with annualized NOI of $2.5 billion and SHOP NOI of $1.3 billion in the fourth quarter [2] Growth Projections - For 2026, management expects normalized FFO per share of $3.78–$3.88, representing roughly 8% growth, and total same-store cash NOI growth of nearly 10% [5][11] - SHOP same-store NOI is projected to grow by 13% to 17%, driven by occupancy and RevPOR improvements [12] Capital Deployment and Investments - Ventas closed approximately $2.5 billion in senior housing investments in 2025 and has an active pipeline targeting another $2.5 billion in 2026 [4][9] - The company has already closed over $800 million in senior housing acquisitions year-to-date in 2026, with a cumulative total of $4.8 billion in acquisitions over a little more than a year [10] Demographic Trends - Management highlighted a "historic demographic inflection point" as baby boomers begin turning 80, with the over-80 population expected to grow by 28% over the next five years [7] - New supply of senior housing remains constrained, with only about 2,500 new units started in Q4 2025, while over 2 million people are expected to turn 80 in 2026 [8] Dividend and Leverage - The board approved an 8% increase in the quarterly dividend, reflecting strong performance and a positive outlook [17] - Leverage improved to approximately 5.2x in Q4, the best level since 2012, with expectations for continued decline in leverage given the growth outlook for 2026 [15]

Group 1 - Sabra Health Care REIT, Inc. will release its 2025 fourth quarter earnings on February 12, 2026, after market close [1] - A conference call to discuss the earnings will take place on February 13, 2026, at 11:00 a.m. Pacific Time, with specific dial-in numbers provided for U.S. and international participants [1] - A digital replay of the conference call will be available on Sabra's website [2] Group 2 - On February 2, 2026, Sabra's board declared a quarterly cash dividend of $0.30 per share, payable on February 27, 2026, to stockholders of record as of February 13, 2026 [2] - Sabra operates as a self-administered, self-managed real estate investment trust (REIT) focused on the healthcare industry in the U.S. and Canada [3]